Equities research analysts at William Blair lifted their Q1 2025 earnings estimates for HealthStream in a research note issued on Tuesday, February 25th. William Blair analyst R. Daniels now forecasts ...
In a report released today, Andy Hsieh from William Blair maintained a Hold rating on Altimmune (ALT – Research Report). The company’s shares ...
William Blair analyst Andy Hsieh maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report) today. The ...
The embedded payments and digital card company agreed to buy European electronic payments provider TransactPay for about $47 ...
Hosted on MSN6d
William Blair Downgrades General Dynamics (GD)Fintel reports that on February 21, 2025, William Blair downgraded their outlook for General Dynamics (NYSE:GD) from ...
Analysts at William Blair upped their FY2025 EPS estimates for Straumann in a report issued on Monday, February 24th. William Blair analyst B. Vazquez now forecasts that the company will post earnings ...
William Blair downgrades Booz Allen, CACI International, Leidos, Parsons and General Dynamics on the heightened risk of ...
The new fund will invest in a niche subset of emerging markets that are 'more challenging for investors to access' ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
KYIV, Ukraine-The U.S. and Ukraine pushed divergent messages over the weekend, with Kyiv pressing for better terms to the mineral-rights deal sought by President Trump, while Washington urged Ukraine ...
Insulet Corporation (NASDAQ:PODD) reported fourth-quarter adjusted EPS of $1.15, down from $1.40 a year ago but beating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback